Cite
MLA Citation
Niels Porksen et al.. “Novel hepato‐preferential basal insulin peglispro (BIL) does not differentially affect insulin sensitivity compared with insulin glargine in patients with type 1 and type 2 diabetes.” Diabetes, obesity & metabolism, vol. 19, no. 4, 2017, pp. 482–488. http://access.bl.uk/ark:/81055/vdc_100044447238.0x000017